The Rheumatoid Panel is a group of blood tests used to aid in the diagnosis and assessment of autoimmune diseases, particularly rheumatoid arthritis (RA). This panel typically includes tests such as:
Rheumatoid Factor (RF)
Anti-Cyclic Citrullinated Peptide Antibodies (Anti-CCP)
Erythrocyte Sedimentation Rate (ESR)
C-reactive Protein (CRP)
And sometimes additional tests like Antinuclear Antibodies (ANA).
RF and Anti-CCP are autoantibodies found in many patients with RA. However, Anti-CCP is more specific and plays a key role in the early diagnosis and differentiation of RA from other joint diseases. Elevated levels of ESR and CRP indicate active inflammation in the body.
Nonetheless, none of these tests alone is definitive. Results must be interpreted in combination with clinical symptoms (such as joint pain and swelling), physical examination, and imaging studies. The panel is also useful for monitoring disease progression, treatment response, and identifying patients at higher risk of joint damage.
It is important to note that around 20–30% of RA patients may be seronegative (negative for both RF and Anti-CCP), so combining laboratory and clinical findings is crucial for accurate diagnosis.
